Goat Feed · KEV

    CISA KEV: Atlassian Multiple Products CVE-2026-21589 (CVSS 4.0 9.3 CRITICAL) - Multiple Products Files or Directories Accessible to External Parties Vulnerability

    This is a vulnerability in Bitbucket Data Center, Confluence Data Center, Jira Service Management Data Center, Jira Software Data Center, Bamboo Data Center. Crowd Data Center, Crucible and Fisheye. This Arbitrary File Access vulnerability allows an unauthenticated attacker to access specific files within the web application root directory in affected versions. Exploitation requires prior knowledge of the target file's exact name and path; this vulnerability does not allow attackers to enumerate or list directory contents. In some configurations, there may be some sensitive files that make this highly severe. This vulnerability allows an unauthenticated remote attacker to access specific files within the web application root directory in affected versions. The vulnerability must be addressed for affected versions of: -- Bitbucket Data Center, introduced in version >= 4.6.0, fix versions: 9.4.26, 10.2.8, 10.5.1 -- Confluence Data Center, introduced in version >= 5.10.0, fix versions 9.2.26, 10.2.19 -- Crowd Data Center, introduced in version >= 2.11.0, fix versions 6.3.7, 7.0.3, 7.1.7, 7.2.4 -- Jira Software Data Center, introduced in version >= 7.1.0, fix versions 9.12.40, 10.3.26, 11.3.12 -- Jira Service Management Data Center, introduced in version >= 3.1.0, fix versions 5.12.40, 10.3.26, 11.3.12 -- Bamboo Data Center >= 7.0.1, fix versions 10.2.24, 12.1.12 -- Crucible, fix versions 4.9.15 -- Fisheye, fix version 4.9.15 -- Exploitation requires prior knowledge of the target file's exact name and path. The vulnerability does not include the capability to enumerate or list directory contents.

    Back to the daily feed
    KEV
    critical

    Blue Goat Risk Score

    Blue Goat Cyber MedTech rubric v1.0 · methodology

    7.8
    of 10
    high
    CVSS technical
    40% · +3.7

    4.0 base 9.3 · CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

    Patient safety
    35% · +1.8

    Delay of care

    Exploit maturity
    15% · +1.5

    On CISA KEV (in-the-wild)

    MedTech exposure
    10% · +0.8

    8/10 network-reachable signals

    How we got to 7.8

    1. 1
      CVSS technical severity (40%)

      Industry-standard exploitability + impact score. We prefer CVSS 4.0 and fall back to 3.1 per the FDA's Feb 2026 premarket cybersecurity guidance. Missing CVSS scores get a neutral 4.0 so unknown vulns are not over- or under-rated.

      4.0 base 9.3 × 40% = +3.72
    2. 2
      Patient safety impact (35%)

      What happens to a patient if this vuln is exploited on a connected device. Auto-inferred from headline, dek, tags, and device class against a curated MedTech keyword library (pacemaker, infusion pump, EHR, PACS, etc.).

      Delay of care → 5 × 35% = +1.75
    3. 3
      Exploit maturity (15%)

      Is anyone actually using this in attacks? KEV listing > weaponized exploit > public PoC > none. KEV alone forces tier=critical regardless of CVSS.

      On CISA KEV (in-the-wild) → 10 × 15% = +1.50
    4. 4
      MedTech exposure (10%)

      How likely this affects clinical operations: presence in our MedTech feed (+4 baseline), network-reachable signals (+3), known device-class tags (+2), identified MedTech vendor (+1).

      Exposure 8/10 × 10% = +0.80

    Tier cutoffs: Critical ≥ 8.5 · High 7.0–8.4 · Notable 4.0–6.9 · Info < 4.0. Full methodology, weights, and changelog at /goatfeed/risk-rubric.

    Other items reviewed by the Blue Goat team.

    Need help acting on this?

    Talk to Blue Goat Cyber

    Penetration testing, SBOM, threat modeling, and 524B submission support for MedTech.